Key result
Changes in cardiomyocyte energy metabolism and mitochondrial function are central to the pathogenesis of sepsis-induced cardiomyopathy and represent potential future therapeutic targets.
Why the study?
The demand of cardiac cells for energy metabolism changes substantially in septic cardiomyopathy, highlighting the need to describe metabolic changes and mitochondrial roles as potential therapeutic targets.
Modulating myocardial energy metabolism and mitochondrial function represents a potential therapeutic strategy for sepsis-induced cardiomyopathy.
Mitochondrial modulation may emerge as a target in sepsis cardiomyopathy; leaves open validation in prospective trials before any practice shift.
Sepsis is a systemic inflammatory response syndrome caused by a variety of dysregulated responses to host infection with life-threatening multi-organ dysfunction. Among the injuries or dysfunctions involved in the course of sepsis, cardiac injury and dysfunction often occur and are associated with the pathogenesis of hemodynamic disturbances, also defined as sepsis-induced cardiomyopathy (SIC). The process of myocardial metabolism is tightly regulated and adapts to various cardiac output demands. The heart is a metabolically flexible organ capable of utilizing all classes of energy substrates, including carbohydrates, lipids, amino acids, and ketone bodies, to produce ATP. The demand of cardiac cells for energy metabolism changes substantially in septic cardiomyopathy, with distinct etiological causes and different times. This review describes changes in cardiomyocyte energy metabolism under normal physiological conditions and some features of myocardial energy metabolism in septic cardiomyopathy and briefly outlines the role of the mitochondria as a center of energy metabolism in the septic myocardium, revealing that changes in energy metabolism can serve as a potential future therapy for infectious cardiomyopathy.
No takes yet. Share an insight, caveat, or question.
Ni et al. (2024) conducted a review in sepsis-induced cardiomyopathy. Changes in cardiomyocyte energy metabolism and mitochondrial function are central to the pathogenesis of sepsis-induced cardiomyopathy and represent potential future therapeutic targets.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: